BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8625180)

  • 1. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
    Dautzenberg B; Chastang C; Arriagada R; Le Chevalier T; Belpomme D; Hurdebourcq M; Lebeau B; Fabre C; Charvolin P; Guérin RA
    Cancer; 1995 Sep; 76(5):779-86. PubMed ID: 8625180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
    Arriagada R; Le Chevalier T; Quoix E; Ruffie P; de Cremoux H; Douillard JY; Tarayre M; Pignon JP; Laplanche A
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1183-90. PubMed ID: 1646194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).
    Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH
    Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.
    Dillman RO; Herndon J; Seagren SL; Eaton WL; Green MR
    J Natl Cancer Inst; 1996 Sep; 88(17):1210-5. PubMed ID: 8780630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients.
    Skarin A; Jochelson M; Sheldon T; Malcolm A; Oliynyk P; Overholt R; Hunt M; Frei E
    J Surg Oncol; 1989 Apr; 40(4):266-74. PubMed ID: 2538680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
    Park JH; Shim YM; Baek HJ; Kim MS; Choe DH; Cho KJ; Lee CT; Zo JI
    Ann Thorac Surg; 1999 Nov; 68(5):1821-6. PubMed ID: 10585065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined chemotherapy (cisplatin, cyclophosphamide, lomustine and vincristine) and multifractionation radiotherapy in inoperable nonmetastatic squamous cell lung cancer.
    Baumöhl J; Jurga L; Klimo J; Jutka K; Zábranská M
    Neoplasma; 1992; 39(1):59-63. PubMed ID: 1528305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques.
    Dautzenberg B; Arriagada R; Chammard AB; Jarema A; Mezzetti M; Mattson K; Lagrange JL; Le Pechoux C; Lebeau B; Chastang C
    Cancer; 1999 Jul; 86(2):265-73. PubMed ID: 10421262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
    Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Tarayre M; Lacombe-Terrier MJ; Douillard JY; Laplanche A
    J Natl Cancer Inst; 1991 Mar; 83(6):417-23. PubMed ID: 1847977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
    Kreuter M; Vansteenkiste J; Fischer JR; Eberhardt WE; Zabeck H; Kollmeier J; Serke M; Frickhofen N; Reck M; Engel-Riedel W; Neumann S; Thomeer M; Schumann C; De Leyn P; Graeter T; Stamatis G; Griesinger F; Thomas M;
    J Thorac Oncol; 2016 Jan; 11(1):85-93. PubMed ID: 26762743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
    Xu G; Rong T; Lin P
    Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
    Feld R; Rubinstein L; Thomas PA
    Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
    Holmes EC; Hill LD; Gail M
    Ann Surg; 1985 Sep; 202(3):335-41. PubMed ID: 3899029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.